Concept of the Method
|
|
assessment of protein expression using antigen-specific antibodies |
assessment of chromogenic effect in an enzymatic reaction |
assessment of chromosomal aberration using a fluorescent probe |
Advantages
|
preparation
|
|
-
-
easy manual preparation [8]
-
-
automated preparation possible (Ventana BenchMark—USA) [2,7]
-
-
permanent result of staining [2,5]
|
-
-
easy manual preparation [8]
-
-
short preparation thanks to fast hybridization buffer
-
-
automated preparation possible (e.g., Ventana Medical System, Tucson, USA) [3]
|
analysis
|
-
-
low-priced equipment for analysis (light microscope) [2]
-
-
automated analysis possible, e.g., ACIS, ChromaVision Medical Systems (San Juan Capistrano, CA) [3], or Applied Spectral Imaging, (Israel)
-
-
simple system of result evaluation (0, 1+, 2+, 3+) [9,10]
|
-
-
low-priced equipment for analysis (light microscope) [2,5]
-
-
automated analysis possible (e.g., Applied Spectral Imaging, Israel)
-
-
assessment of copy-number alterations and cells morphology possible at the same time [2,5,11]
-
-
quantitative interpretation of result [2,11]
-
-
use of internal control possible [11]
|
-
-
possible automatized scoring (e.g., Applied Spectral Imaging, Israel)
-
-
quantitative interpretation of result [2,8,10]
-
-
established cut-off values for probes [7,9,12,13,14,15]
|
other
|
|
|
-
-
allows distinguishing HER2 amplification from polysomy 17 (pseudoamplification) [9]
-
-
allows detecting rearrangement and deletion at the same time (ALK, ROS1) [7]
-
-
allows detecting rearrangement with many possible gene partners (ALK, EWSR1) [16]
-
-
presence of control cells (nonneoplastic) on the same slide (internal control of preparation) [3]
-
-
analysis of concordance of results between independent observers [2]
|
Disadvantages
|
preparation
|
|
|
|
analysis
|
-
-
semi-quantitative interpretation of results (subjective assessment) [3,17]
-
-
possible discrepancies between results (e.g., for score 2+) due to qualitative interpretation of result based on subjective judgment
-
-
necessity of re-evaluation of result of HER2 (2+) using FISH [2]
-
-
false positive result of overexpression for 3+ due to polysomy 17 (in breast cancer)
-
-
necessity of re-evaluation of positive result of ALK using FISH (sometimes negative result as well) [18]
|
-
-
no ratio result for amplification [3]
-
-
necessity of extra staining to exclude polysomy, e.g., of chromosome 17 [3]
-
-
possible problems with interpretation of fusion signals [7]
|
-
-
specialized equipment (fluorescence microscope with a set of filters)
-
-
limited assessment of cell features (size and shape) [2]
-
-
possible discrepancies between independent observers in low-level amplification cases, equivocal case (HER2) [3]
-
-
possible discrepancies between independent observers in borderline distance between probe parts [10]
|
other
|
- |
- |
|
|
Examples of solid tumors with use of the method
|
|
|
|
-
-
breast cancer [3,9,11]
-
-
gastric cancer [30]
-
-
lung cancer [7,31]
-
-
glioma [22]
-
-
ovarian cancer [23,24]
-
-
soft tissue sarcomas: EWS, SS, DFSP [14,26,32,33]
|